Curexsys GmbH
PrivateLast Round
Seed
Dec 9, 2020
Total Funding Raised
$9.97M
Company Overview
Curexsys GmbH is a biotechnology company that develops therapeutic exosome-based treatments for age-related and inflammatory conditions using a proprietary traceless immune-affinity isolation technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curexsys GmbH Comparables
Compare Curexsys GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EVerZom | 80% | |
| ConvEyXO | 79% | |
| Carrier Biomed (Suzhou) Co., Ltd. | 77% |
Curexsys GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 9, 2020 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 9, 2020
$10M round led by Evotec and Sartorius Aktiengesellschaft.
Curexsys GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Curexsys GmbH's valuation, stock price, and market status.
Is Curexsys GmbH a public or private company?
Curexsys GmbH is a private company.
What is the current stock price of Curexsys GmbH?
Curexsys GmbH is a private company with no public stock price. Caplight tracks Curexsys GmbH's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Curexsys GmbH worth (valuation)?
Valuation information for Curexsys GmbH is not publicly available.
Can I buy Curexsys GmbH stock?
Curexsys GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Curexsys GmbH's last funding round?
Curexsys GmbH's most recent funding round was Seed on December 9, 2020.
Who are the main investors in Curexsys GmbH?
Investor information for Curexsys GmbH is not publicly disclosed.
Will Curexsys GmbH IPO soon?
No public IPO plans have been announced for Curexsys GmbH.
How can I track Curexsys GmbH secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Curexsys GmbH's secondary market activity and sign up for updates.